November 5, 2024
November 4, 2024
November 4, 2024
Microbiological contamination is a critical concern in pharmaceutical manufacturing, particularly for drug products purporting to be sterile.
Today, the Pharma 4.0 market is projected to reach $11.2 billion by 2030, growing at a CAGR of 18.2%, reinforcing the industry’s commitment to efficiency, compliance, and innovation.
No one wants to take a tablet where the API (active pharmaceutical ingredient) is not absorbed. As these terms can be confusing, we will start with some definitions and testing apparatus.